SEL Launches Clinical Trial for Autism Screening Device in Inland Northwest
Dailyfly News
Schweitzer Engineering Laboratories (SEL) has launched a clinical trial to evaluate the APS Detect handheld pupillometer, a device that measures pupil response to light to help identify children who may have autism spectrum disorder (ASD) at an earlier age. The study, involving 330 participants aged 2 to 4 years across multiple locations in the Inland Northwest, aims to assess the device's effectiveness in supporting early autism screening. The device, developed by SEL based on research from Washington State University, is intended to complement existing screening practices rather than replace them.
All articles from 16 November 2026. Summaries are AI-generated and may contain errors; the linked article is the authority.
Get this news by email
Daily or as a weekly roundup in your inbox. You confirm your address first; every email has an unsubscribe link. For another topic or language, use the subscribe page.